PHARMACEUTICAL COMBINATIONS COMPRISING A DPP-4 INHIBITOR AND A 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVE

摘要

The present invention provides novel combination products comprising 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) and a DPP-4 Inhibitor and pharmaceutical compositions comprising the same for treating disorders that require preserving physiological levels of endogenous GLP-1. 1,3-diphenylprop-2-en-1-one derivative of General Formula (I) potentiates DPP-4 Inhibitor effects and their combination can be used in methods for treating a condition mediated by GLP-1, such as metabolic disorders.